These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Ecthyma gangrenosum: a manifestation of Pseudomonas sepsis in three paediatric patients. Chan YH; Chong CY; Puthucheary J; Loh TF Singapore Med J; 2006 Dec; 47(12):1080-3. PubMed ID: 17139406 [TBL] [Abstract][Full Text] [Related]
6. [Septicemia caused by Pseudomonas aeruginosa serotype O 16 in a hemato-oncology department. Review of 17 cases]. Campillo B; Richet H; Rio B; Marie JP; Arrago JP; Lagrange P; Zittoun R Ann Med Interne (Paris); 1985; 136(8):629-33. PubMed ID: 3938628 [TBL] [Abstract][Full Text] [Related]
7. [Pseudomonas sepsis with ecthyma gangrenosum in an acute myeloid leukemia patient]. Obara Y; Nagai T; Mori M; Ohmine K; Toshima M; Komatsu N; Ozawa K Rinsho Ketsueki; 2004 Oct; 45(10):1138-40. PubMed ID: 15553052 [TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa bacteraemia. Is pancreatobiliary disease a risk factor? Chen SC; Lawrence RH; Byth K; Sorrell TC Med J Aust; 1993 Nov; 159(9):592-7. PubMed ID: 8232033 [TBL] [Abstract][Full Text] [Related]
9. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [TBL] [Abstract][Full Text] [Related]
10. Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis. Zelenitsky SA; Harding GK; Sun S; Ubhi K; Ariano RE J Antimicrob Chemother; 2003 Oct; 52(4):668-74. PubMed ID: 12951354 [TBL] [Abstract][Full Text] [Related]
11. Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations. Wu YL; Scott EM; Po AL; Tariq VN APMIS; 1999 Jun; 107(6):585-92. PubMed ID: 10379686 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa. Patzer J; Gieburowska R; Dzierzanowska D Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544 [TBL] [Abstract][Full Text] [Related]
13. Adult Pseudomonas aeruginosa meningitis: high incidence of underlying medical and/or postneurosurgical conditions and high mortality rate. Huang CR; Lu CH; Chuang YC; Tsai NW; Chang CC; Chen SF; Wang HC; Chien CC; Chang WN Jpn J Infect Dis; 2007 Nov; 60(6):397-9. PubMed ID: 18032844 [TBL] [Abstract][Full Text] [Related]
14. [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii]. Taşbakan MS; Pullukçu H; Ekren PK; Oz AT; Midilli M; Aydemir S; Gürgün A; Başoğlu OK; Bacakoğlu F Mikrobiyol Bul; 2009 Jan; 43(1):61-70. PubMed ID: 19334381 [TBL] [Abstract][Full Text] [Related]
15. [Prevention and antibiotic treatment of Pseudomonas aeruginosa septicemia]. Deng GH Zhonghua Yi Xue Za Zhi; 1993 Oct; 73(10):599-601, 637. PubMed ID: 8313182 [TBL] [Abstract][Full Text] [Related]
16. Pandrug-resistant Pseudomonas aeruginosa among hospitalised patients: clinical features, risk-factors and outcomes. Wang CY; Jerng JS; Chen KY; Lee LN; Yu CJ; Hsueh PR; Yang PC Clin Microbiol Infect; 2006 Jan; 12(1):63-8. PubMed ID: 16460548 [TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved? Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923 [TBL] [Abstract][Full Text] [Related]
18. Risk of emergence of Pseudomonas aeruginosa resistance to beta-lactam antibiotics in intensive care units. Georges B; Conil JM; Dubouix A; Archambaud M; Bonnet E; Saivin S; Lauwers-Cancès V; Cristini C; Cougot P; Decun JF; Mathe O; Chabanon G; Marty N; Seguin T; Houin G Crit Care Med; 2006 Jun; 34(6):1636-41. PubMed ID: 16557152 [TBL] [Abstract][Full Text] [Related]
19. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study. Deal EN; Micek ST; Reichley RM; Ritchie DJ Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902 [TBL] [Abstract][Full Text] [Related]
20. [Does a rational therapeutic plan exist for nosocomial bacteremia caused by Pseudomonas aeruginosa?]. Torné J; García Flores A; Tomás S; Serrano R Med Clin (Barc); 1987 Oct; 89(13):572. PubMed ID: 3121961 [No Abstract] [Full Text] [Related] [Next] [New Search]